Surya Pharmaceuticals

Chandigarh-based pharmaceutical firm acquires US brand for $22mn

Hariom-Bhatia-Surya-PharmaChandigarh-based Rs 1,144-crore Surya Pharmaceuticals has acquired US-based over-the-counter (OTC) analgesic drug brand ActivOn including its global marketing rights by paying $22 million.

Surya Pharmaceuticals, having net revenue of Rs 1,144 crore in financial year 2009-10, has already got assurance from Exim Bank that will finance the acquisition, according to firm's filing before the Bombay Stock Exchange (BSE).

Hold Surya Pharma With Stop Loss Of Rs 260

Hold Surya Pharma With Stop Loss Of Rs 260Technical analyst MB Singh has maintained 'hold' rating on Surya Pharmaceutical Limited stock with a stop loss of Rs 260.

According to analyst, the investors can exit on every rally.

The stock of the company, on December 21, closed at Rs 292 on the Bombay Stock Exchange (BSE).

The share price has seen a 52-week high of Rs 355.90 and a low of Rs 142.20 on BSE.

Crocs signed to market medical footwear for India

Crocs signed to market medical footwear for IndiaSurya Pharmaceuticals has signed a marketing agreement with Crocs, a footwear manufacturing company based in US for marketing medical footwear in India. This exclusive marketing alliance tends to give revenue of Rs 1 billion in next two years to the former company.

Crocs has already gained lot of popularity in the field of making medical foot wears, particularly foot wears which are made for those who are suffering from some foot problem or those who have arthritis or diabetes.

Syndicate content